Hospital organization sees impressive returns from POCUS integration

Point of care ultrasound (POCUS) helped one organization improve workflow efficiency and increase diagnostic accuracy all while boosting revenues. 

The University of Rochester Medical Center has been able to successfully deploy hundreds of POCUS devices accompanied by an ultrasound enterprise platform across 64 academic departments and clinical programs since 2021. The medical center—which partnered with Butterfly Network, a digital health company that develops POCUS devices and software to bring ultrasound technology to the bedside—detailed how they were able to improve patient care and clinical workflows with the help of POCUS in a new academic paper published in the Journal of Clinical Imaging Science on Sept. 16. 

“Point-of-care ultrasound has emerged as a cost-effective diagnostic tool that significantly augments physical examinations,” corresponding author of the paper David Waldman, with the Department of Imaging Sciences at the University of Rochester, and colleagues wrote. “Positioned as an extension of traditional examination methods, particularly appealing to the upcoming generation of clinicians, it holds promise in potentially replacing the stethoscope in various medical assessments and procedures.” 

Since the project started, nearly 50,000 scanning sessions have been completed, resulting in over 175,000 images and 15,524 finalized reports. POCUS also enabled earlier detection of numerous ailments, such as bladder tumors, cholecystitis, pneumonia, pleural effusions, endocarditis, fluid overload and more. So far, the organization has recorded a 116% increase in hospital charges owed to the POCUS system, “underscoring the tangible impact of POCUS integration,” the authors noted. 

“Our phased deployment of Butterfly devices and Compass software has yielded impressive clinical and administrative results at URMC to date. URMC is proud to be at the forefront of the wide-scale deployment of innovative point-of-care ultrasound technology, and we believe it shows promise as the right care model for the medical community at large,” Michael F. Rotondo, MD, CEO of the URM Faculty Group and senior VP of URMC, said in a statement on the findings. 

The case study highlighted some issues with implementing POCUS into clinical workflows; More experienced providers were less willing to adopt new procedures, and many expressed legal concerns stemming from the risk of missing an important finding, which is a universal concern in radiology in general, the group noted.  

Learn more about the project, including how those involved believe POCUS will impact patient care in the future, here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup